ropeginterferon alfa-2b - Mondialnews

Browsing: ropeginterferon alfa-2b

Canada By Atticus ReedJuly 7, 2026

PharmaEssentia Gains Health Canada Approval for BESREMi® to Transform Polycythemia Vera Treatment

PharmaEssentia is thrilled to announce that Health Canada has approved BESREMi® (ropeginterferon alfa-2b), a groundbreaking treatment offering new hope to patients battling polycythemia vera (PV), a rare and complex blood disorder

1 - 2 - 3 - 4 - 5 - 6 - 7 - 8

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31